Craig I Coleman
Overview
Explore the profile of Craig I Coleman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
327
Citations
4432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fan H, Bessada Y, Coleman C
Res Pract Thromb Haemost
. 2025 Mar;
9(1):102688.
PMID: 40060367
Background: Evaluations of andexanet alfa for the reversal of factor Xa inhibitor-associated bleeding have been small, with cohorts drawn from single/limited sites. Delays in providing anticoagulation reversal due to hospital...
2.
Coleman C, Bylyku J, Latifi A, Lovelace B, Shan R, Miriyapalli L, et al.
J Fungi (Basel)
. 2025 Feb;
11(2).
PMID: 39997455
There are scarce data comparing inpatient mortality, length of stay (LOS) and all-cause hospital costs in disseminated coccidioidomycosis (DCM) vs. isolated pulmonary coccidioidomycosis (IPCM). We assessed the burden of hospital...
3.
Donovan F, Bresnik M, Lovelace B, Pizzicato L, Anupindi V, DeKoven M, et al.
Clin Microbiol Infect
. 2025 Feb;
PMID: 39922463
Objectives: This study aims to describe baseline characteristics, antifungal treatment patterns, healthcare utilization, costs, and mortality in patients with central nervous system (CNS) and non-CNS disseminated coccidioidomycosis. Methods: A retrospective...
4.
Alexander B, Johnson M, Bresnik M, Anupindi V, Pizzicato L, DeKoven M, et al.
Open Forum Infect Dis
. 2025 Jan;
12(1):ofae747.
PMID: 39829639
Background: Early antifungal initiation in invasive aspergillosis (IA) is recommended. Changing antifungals occurs for a myriad of reasons but associated costs are unclear. Methods: US claims data for adults admitted...
5.
Alexander B, Johnson M, Bresnik M, Anupindi V, Pizzicato L, DeKoven M, et al.
J Fungi (Basel)
. 2024 Dec;
10(12).
PMID: 39728372
Changes to antifungal therapy (AFT) in invasive aspergillosis (IA) may occur due to intolerance, side effects, drug interactions, or lack of response. We describe AFT change patterns in IA patients....
6.
Johannes C, Ziemiecki R, Pladevall-Vila M, Ebert N, Kovesdy C, Thomsen R, et al.
Diabetes Ther
. 2024 Dec;
16(2):205-226.
PMID: 39688776
Introduction: The clinical landscape for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is rapidly evolving. As part of the FOUNTAIN platform (NCT05526157; EUPAS48148),...
7.
Coleman C, Donovan F, Miriyapalli L, Shan R, Lovelace B
Open Forum Infect Dis
. 2024 Dec;
11(12):ofae706.
PMID: 39660027
Coccidioidal meningitis (CM) requires lifelong aggressive management, often necessitating hospitalization. In the National Inpatient Sample (2019-2021), CM hospitalizations (N = 2305) were associated with frequent CM-related procedures (63.6% [95% confidence...
8.
Dobesh P, Coleman C, Danese M, Lesen E, Chang R, Odelade O, et al.
J Am Coll Emerg Physicians Open
. 2024 Nov;
5(6):e13333.
PMID: 39524040
Objectives: This study describes clinical characteristics and management strategies for patients with factor Xa (FXa) inhibitor-related traumatic non-intracranial bleeds who were treated with andexanet alfa or four-factor prothrombin complex concentrate...
9.
Dobesh P, Fermann G, Christoph M, Koch B, Lesen E, Chen H, et al.
Res Pract Thromb Haemost
. 2024 Jul;
8(4):102429.
PMID: 38993619
No abstract available.
10.
Kreutz R, Deray G, Floege J, Gwechenberger M, Hahn K, Luft A, et al.
JACC Adv
. 2024 Jun;
3(2):100813.
PMID: 38939389
Background: Treatment with vitamin K antagonists (VKAs) has been linked to worsening of kidney function in patients with atrial fibrillation (AF). Objectives: XARENO (Factor XA-inhibition in RENal patients with non-valvular...